批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2023/12/13 |
SUPPL-18(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2020/04/03 |
SUPPL-17(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2019/05/23 |
SUPPL-14(补充) |
Approval |
Efficacy |
PRIORITY
|
|
|
2018/05/03 |
SUPPL-13(补充) |
Approval |
Efficacy |
PRIORITY
|
|
|
2016/12/22 |
SUPPL-11(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2016/03/09 |
SUPPL-10(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2013/12/23 |
SUPPL-8(补充) |
Approval |
Manufacturing (CMC) |
N/A
|
|
|
2013/02/28 |
SUPPL-7(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2012/04/16 |
SUPPL-6(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2011/08/24 |
SUPPL-4(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2011/06/20 |
SUPPL-5(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2011/04/26 |
SUPPL-3(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2011/04/26 |
SUPPL-2(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2011/04/26 |
SUPPL-1(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2010/01/04 |
ORIG-1(原始申请) |
Approval |
Type 3 - New Dosage Form |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
与本品治疗等效的药品
活性成分:PREGABALIN 剂型/给药途径:SOLUTION;ORAL 规格:20MG/ML 治疗等效代码:AA
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
022488 |
001 |
NDA |
LYRICA |
PREGABALIN |
SOLUTION;ORAL |
20MG/ML |
Prescription |
Yes |
Yes |
AA |
2010/01/04
|
UPJOHN |
207623 |
001 |
ANDA |
PREGABALIN |
PREGABALIN |
SOLUTION;ORAL |
20MG/ML |
Prescription |
No |
No |
AA |
2019/07/19
|
ALKEM LABS LTD |
212604 |
001 |
ANDA |
PREGABALIN |
PREGABALIN |
SOLUTION;ORAL |
20MG/ML |
Prescription |
No |
No |
AA |
2022/02/18
|
ANDA REPOSITORY |